Regeneron to launch Phase 3 trials of antibody 'cocktail' for COVID-19
Monday, July 6, 2020 - 15:10
in Health & Medicine
Drugmaker Regeneron announced plans Monday to begin Phase 3 clinical trials of a "double antibody cocktail" for use as a possible treatment for COVID-19.